Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis

被引：2
|
作者：
Pogosova, Nana [1 ]
Bosch, Jacqueline
Bhatt, Deepak L. [4 ]
Fox, Keith A. A. [5 ]
Connolly, Stuart J. [2 ,3 ,6 ]
Alings, Marco [7 ]
Verhamme, Peter [8 ]
Muehlhofer, Eva [9 ]
Shestakovska, Olga [2 ]
Yusuf, Salim [2 ,3 ,6 ]
Eikelboom, John W. [2 ,3 ,6 ]
机构：
[1] Natl Med Res Ctr Cardiol, Moscow, Russia
[2] Populat Hlth Res Inst, Hamilton, ON, Canada
[3] McMaster Univ, Hamilton, ON, Canada
[4] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[5] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland
[6] Hamilton Hlth Sci, Hamilton, ON, Canada
[7] Amphia Ziekenhuis & WCN, Utrecht, Netherlands
[8] Univ Leuven, Leuven, Belgium
[9] Bayer AG, Wuppertal, Germany
来源：
CIRCULATION | 2022年 / 145卷 / 25期
关键词：
aspirin; coronary artery disease; peripheral artery disease; rivaroxaban; venous thromboembolism;
D O I：
10.1161/CIRCULATIONAHA.122.059405
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1875 / 1877
页数：3
相关论文
共 50 条
  • [1] Comparable efficacy of 100 mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty: a randomized controlled trial
    Ren, Yi
    Cao, Shi-Liang
    Li, Zeng
    Luo, Tim
    Feng, Bin
    Weng, Xi-Sheng
    CHINESE MEDICAL JOURNAL, 2021, 134 (02) : 164 - 172
  • [2] Comparable efficacy of 100 mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty: a randomized controlled trial
    Ren Yi
    Cao Shi-Liang
    Li Zeng
    Luo Tim
    Feng Bin
    Weng Xi-Sheng
    中华医学杂志英文版, 2021, 134 (02) : 164 - 172
  • [3] Coagulation markers in patients with venous thromboembolism treated with 10 mg apixaban twice daily
    Ono, Ryohei
    Fukushima, Kenichi
    Yamazaki, Tatsuro
    Yamashita, Daichi
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Nishimura, Kazutaka
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (02) : 159 - 166
  • [4] Coagulation markers in patients with venous thromboembolism treated with 10 mg apixaban twice daily
    Ryohei Ono
    Kenichi Fukushima
    Tatsuro Yamazaki
    Daichi Yamashita
    Hidehisa Takahashi
    Yasuhiko Hori
    Kazutaka Nishimura
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2022, 395 : 159 - 166
  • [5] Combination of Xarelto® (Rivaroxaban) 2.5 mg Twice Daily and Acetylsalicylic Acid is Now Recommended for the Treatment of Patients with Chronic Coronary Heart Disease
    不详
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2019, 15 (06) : 930 - 930
  • [6] Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, periphera artery disease, or both
    Fox, Keith A. A.
    Anand, Sonia S.
    Aboyans, Victor
    Cowie, Martin R.
    Debus, E. Sebastian
    Zeymer, Uwe
    Monje, Danja
    Vogtlaender, Kai
    Lawatscheck, Robert
    Gay, Alain
    AMERICAN HEART JOURNAL, 2020, 222 : 166 - 173
  • [7] Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement
    Mueck, Wolfgang
    Borris, Lars C.
    Dahl, Ola E.
    Haas, Sylvia
    Huisman, MennoV.
    Kakkar, Ajay K.
    Kalebo, Peter
    Muelhofer, Eva
    Misselwitz, Frank
    Eriksson, Bengt I.
    THROMBOSIS AND HAEMOSTASIS, 2008, 100 (03) : 453 - 461
  • [8] Aspirin and recurrent venous thromboembolism in patients with symptomatic atherosclerosis: retrospective cohort study
    Milan, M.
    Noventa, F.
    Ghirarduzzi, A.
    Pengo, V.
    Vedovetto, V.
    Filippi, L.
    Campello, E.
    Prandoni, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (10) : 2205 - 2206
  • [9] Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism
    Laliberte, Francois
    Bookhart, Brahim K.
    Nelson, Winnie W.
    Lefebvre, Patrick
    Schein, Jeff R.
    Rondeau-Leclaire, Jonathan
    Duh, Mei Sheng
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2013, 6 (03): : 213 - 224
  • [10] Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism
    François Laliberté
    Brahim K. Bookhart
    Winnie W. Nelson
    Patrick Lefebvre
    Jeff R. Schein
    Jonathan Rondeau-Leclaire
    Mei Sheng Duh
    The Patient - Patient-Centered Outcomes Research, 2013, 6 : 213 - 224
12345